OTC:TEVJF | Free Cash Flow | TEVA PHARMACEUTICAL INDUSTRIES LTD

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2007-12-31 to 2026-06-30
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-06-30$411M
2026-03-31-$40M
2025-12-31$1.16B
2025-09-30$369M
2025-06-30$227M
2025-03-31-$105M
2024-12-31$575M
2024-09-30$693M
2024-06-30$103M
2024-03-31-$124M
2023-12-31$1.18B
2023-09-30$5M
2023-06-30$324M$119M$205M
2023-03-31-$145M$139M-$284M
2022-12-31$973M$142M$831M
2022-09-30$543M
2022-06-30$123M$127M-$4M
2022-03-31-$49M$157M-$206M
2021-12-31$456M$153M$303M
2021-03-31-$405M$150M-$555M-720.78%
2020-12-31$331M$176M$155M103.33%
2020-03-31$305M$128M$177M256.52%
2019-12-31$538M$119M$419M384.40%
2019-03-31$112M$125M-$13M
2018-12-31$367M$213M$154M
2018-03-31$1.5B$163M$1.33B119.02%
2017-12-31$859M$267M$592M
2017-03-31$136M$202M-$66M-10.23%
2016-12-31$1.43B$333M$1.09B
2016-03-31$1.38B$172M$1.2B189.31%
2015-12-31$1.62B$248M$1.37B273.40%
2015-03-31$1.35B$185M$1.17B262.11%
2014-12-31$1.75B$300M$1.45B211.35%
2014-03-31$898M$225M$673M90.46%
2013-12-31$816M$314M$502M132.11%
2013-03-31$1.1B$264M$838M133.02%
2012-12-31$1.58B$327M$1.25B390.63%
2012-03-31$756M$274M$482M56.11%
2011-12-31$1.43B$317M$1.11B219.57%
2011-03-31$900M$234M$666M87.52%
2010-12-31$1.1B$234M$868M112.58%
2010-03-31$886M$165M$721M101.12%
2009-12-31$957M$212M$745M196.57%
2009-03-31$733M$160M$573M127.05%
2008-12-31$969M$181M$788M
2008-03-31$746M$142M$604M434.53%

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31$1.65B
2024-12-31$1.25B
2023-12-31$1.37B
2022-12-31$1.59B$548M$1.04B
2021-12-31$798M$562M$236M56.59%
2020-12-31$1.22B$578M$638M
2019-12-31$748M$525M$223M
2018-12-31$2.45B$651M$1.8B
2017-12-31$2.23B$874M$1.35B
2016-12-31$3.89B$901M$2.99B908.51%
2015-12-31$5.54B$772M$4.77B300.38%
2014-12-31$5.13B$929M$4.2B137.41%
2013-12-31$3.24B$1.03B$2.21B173.84%
2012-12-31$4.57B$1.1B$3.47B176.67%
2011-12-31$4.13B$1.05B$3.08B111.67%
2010-12-31$4.14B$710M$3.43B102.85%
2009-12-31$3.37B$719M$2.65B132.70%
2008-12-31$3.23B$681M$2.55B418.72%
2007-12-31$1.81B$542M$1.27B66.41%

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.